Faes Farma Past Earnings Performance
Past criteria checks 4/6
Faes Farma has been growing earnings at an average annual rate of 12.3%, while the Pharmaceuticals industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 7% per year. Faes Farma's return on equity is 13.8%, and it has net margins of 19.1%.
Key information
12.3%
Earnings growth rate
9.1%
EPS growth rate
Pharmaceuticals Industry Growth | 14.1% |
Revenue growth rate | 7.0% |
Return on equity | 13.8% |
Net Margin | 19.1% |
Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Faes Farma makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 23 | 469 | 90 | 97 | 0 |
31 Mar 23 | 467 | 91 | 96 | 0 |
31 Dec 22 | 462 | 90 | 92 | 0 |
30 Sep 22 | 460 | 86 | 113 | 0 |
30 Jun 22 | 466 | 88 | 91 | 0 |
31 Mar 22 | 449 | 88 | 111 | 0 |
31 Dec 21 | 429 | 82 | 87 | 0 |
30 Sep 21 | 416 | 81 | 107 | 0 |
30 Jun 21 | 398 | 74 | 106 | 0 |
31 Mar 21 | 394 | 73 | 104 | 0 |
31 Dec 20 | 411 | 73 | 105 | 0 |
30 Sep 20 | 408 | 77 | 92 | 0 |
30 Jun 20 | 407 | 73 | 106 | 0 |
31 Mar 20 | 409 | 68 | 106 | 0 |
31 Dec 19 | 383 | 64 | 104 | 0 |
30 Sep 19 | 379 | 60 | 114 | 0 |
30 Jun 19 | 363 | 59 | 97 | 0 |
31 Mar 19 | 351 | 54 | 95 | 0 |
31 Dec 18 | 340 | 52 | 94 | 0 |
30 Sep 18 | 334 | 51 | 87 | 0 |
30 Jun 18 | 330 | 49 | 86 | 0 |
31 Mar 18 | 308 | 47 | 81 | 0 |
31 Dec 17 | 282 | 41 | 77 | 0 |
30 Sep 17 | 266 | 39 | 70 | 0 |
30 Jun 17 | 250 | 39 | 67 | 0 |
31 Mar 17 | 241 | 38 | 66 | 0 |
31 Dec 16 | 237 | 37 | 66 | 0 |
30 Sep 16 | 226 | 35 | 64 | 0 |
30 Jun 16 | 222 | 34 | 63 | 0 |
31 Mar 16 | 220 | 32 | 62 | 0 |
31 Dec 15 | 214 | 30 | 61 | 0 |
30 Sep 15 | 207 | 28 | 59 | 1 |
30 Jun 15 | 203 | 27 | 58 | 0 |
31 Mar 15 | 196 | 26 | 45 | 0 |
31 Dec 14 | 198 | 25 | 58 | 0 |
30 Sep 14 | 195 | 23 | 60 | 1 |
30 Jun 14 | 194 | 24 | 60 | 1 |
31 Mar 14 | 192 | 20 | 60 | 1 |
31 Dec 13 | 193 | 23 | 60 | 1 |
30 Sep 13 | 196 | 21 | 65 | 1 |
30 Jun 13 | 197 | 23 | 65 | 1 |
31 Mar 13 | 191 | 21 | 65 | 1 |
31 Dec 12 | 190 | 20 | 65 | 1 |
Quality Earnings: FAEE has high quality earnings.
Growing Profit Margin: FAEE's current net profit margins (19.1%) are higher than last year (19%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: FAEE's earnings have grown by 12.3% per year over the past 5 years.
Accelerating Growth: FAEE's earnings growth over the past year (1.4%) is below its 5-year average (12.3% per year).
Earnings vs Industry: FAEE earnings growth over the past year (1.4%) exceeded the Pharmaceuticals industry -41.9%.
Return on Equity
High ROE: FAEE's Return on Equity (13.8%) is considered low.